GANX · Categories · Form 3

GANX - SEC Form 3 initial insider statements

Gain Therapeutics Inc. (GANX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for GANX

• 792d
  SEC Form 3 filed by new insider Mack Gene

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1154d
  SEC Form 3 filed by new insider Ballantyne Charles Evan

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1266d
  SEC Form 3 filed by new insider Fuggetta Gianluca

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1510d
  SEC Form 3 filed by new insider Richman Eric I (Amendment)

  3/A - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1624d
  SEC Form 3 filed by new insider Alder Matthias

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1898d
  SEC Form 3 filed by Manolo Bellotto

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1898d
  SEC Form 3 filed by Salvatore Calabrese

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1898d
  SEC Form 3 filed by Scott Jeffrey Riley

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)
• 1898d
  SEC Form 3 filed by Peter Hans Hasler

  3 - Gain Therapeutics, Inc. (0001819411) (Issuer)

Other GANX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends